Nifedipine Tablet, Extended Release
Product Images NDC 51407-624

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 51407-624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-622-01 (51407 622 01)

Nifedipine 30 mg extended-release tablets label showing 100 tablets per container. The label includes storage instructions, dosage form, and manufacturer details. It also contains warnings about swallowing tablets whole and protecting from light and moisture. Marketed by GSMS, Incorporated.*

FDA Label Image

51407-623-01 (51407 623 01)

Nifedipine 60 mg extended-release oral tablets label from Golden State Medical Supply, Inc., containing 100 tablets. The label includes dosage strength, quantity, and storage instructions, and notes that the tablets are film-coated and should be swallowed whole. Manufactured by Novast Laboratories Ltd., marketed by GSMS, Incorporated.*

FDA Label Image

51407-624-01 (51407 624 01)

Nifedipine 90 mg extended-release oral tablets label by Golden State Medical Supply, Inc. This label indicates a package size of 100 tablets and features storage instructions, pharmacist dispensing guidance, and a barcode. The label also notes the drug is prescription-only and the tablets should be swallowed whole. Manufactured by Novast Laboratories Ltd.*

FDA Label Image

Image1 (Image 01)

Chemical structure diagram of the active ingredient nifedipine, showing its molecular composition with labeled atoms and functional groups connected by bonds.*

FDA Label Image

Image2 (Image 02)

A data table presenting mean reductions in trough supine blood pressure (systolic/diastolic, mmHg) for Nifedipine extended-release tablets at 30 mg, 60 mg, and 90 mg doses across two studies, with sample sizes (N) and placebo response subtracted.*

FDA Label Image

Image3 (Image 03)

A data table comparing the incidence percentages of various adverse effects between Nifedipine extended-release tablets and placebo. The table lists headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation with corresponding percentages for each group.*

FDA Label Image

Image4 (Image 04)

A data table listing the colors and markings corresponding to different strengths of Nifedipine extended-release tablets by Golden State Medical Supply, Inc. The 30 mg tablets are yellow with 'Novast' on one side and '33' on the other, the 60 mg tablets are pink with 'Novast' and '36', and the 90 mg tablets are brown with 'Novast' and '39'.*

FDA Label Image

Image6 (Image 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.